BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38423645)

  • 1. Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
    Ebata Y; Nakanishi R; Tanaka Y; Kawazoe T; Tajiri H; Zaitsu Y; Nakashima Y; Ota M; Oki E; Yoshizumi T
    Anticancer Res; 2024 Mar; 44(3):1281-1287. PubMed ID: 38423645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
    Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
    Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis.
    Zeng W; Liu Y; Wang C; Yang C; Lin S; Li W
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
    Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
    Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review.
    Arredondo J; Pastor E; Simó V; Beltrán M; Castañón C; Magdaleno MC; Matanza I; Notarnicola M; Ielpo B
    Tech Coloproctol; 2020 Oct; 24(10):1001-1015. PubMed ID: 32666362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Evidence for the Benefits of Neoadjuvant Chemotherapy and Immunotherapy in Colon Cancer: A Concise Review.
    Gupta K; Elfiky A; Patel E
    Discov Med; 2023 Dec; 35(179):928-935. PubMed ID: 38058057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective, Single-arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE Study).
    Ishibe A; Watanabe J; Suwa Y; Nakagawa K; Suwa H; Misumi T; Ota M; Endo I
    Ann Surg; 2022 Jul; 276(1):140-145. PubMed ID: 32941273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Strategies for Locally Advanced Colon Cancer.
    Nair KG; Kamath SD; Chowattukunnel N; Krishnamurthi SS
    Curr Treat Options Oncol; 2024 Mar; 25(3):376-388. PubMed ID: 38349502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy Improves Survival in Patients with Clinical T4b Colon Cancer.
    Dehal A; Graff-Baker AN; Vuong B; Fischer T; Klempner SJ; Chang SC; Grunkemeier GL; Bilchik AJ; Goldfarb M
    J Gastrointest Surg; 2018 Feb; 22(2):242-249. PubMed ID: 28933016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of surgical treatment after neoadjuvant chemotherapy for cT4N+ colon cancer].
    Li YJ; Wu YL; Cui J; Zhang L; Zheng W; Zhu YL; Yang L; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):454-459. PubMed ID: 31216833
    [No Abstract]   [Full Text] [Related]  

  • 12. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.
    Morton D; Seymour M; Magill L; Handley K; Glasbey J; Glimelius B; Palmer A; Seligmann J; Laurberg S; Murakami K; West N; Quirke P; Gray R;
    J Clin Oncol; 2023 Mar; 41(8):1541-1552. PubMed ID: 36657089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemotherapy for Locally Advanced T4 Colon Cancer: A Nationwide Propensity-Score Matched Cohort Analysis.
    de Gooyer JM; Verstegen MG; 't Lam-Boer J; Radema SA; Verhoeven RHA; Verhoef C; Schreinemakers JMJ; de Wilt JHW
    Dig Surg; 2020; 37(4):292-301. PubMed ID: 31661689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection.
    Yuan Y; Xiao WW; Xie WH; Cai PQ; Wang QX; Chang H; Chen BQ; Zhou WH; Zeng ZF; Wu XJ; Liu Q; Li LR; Zhang R; Gao YH
    BMC Cancer; 2021 Feb; 21(1):179. PubMed ID: 33607964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy in patients undergoing colonic resection for locally advanced nonmetastatic colon cancer: A nationwide propensity score matched cohort study.
    Laursen M; Dohrn N; Gögenur I; Klein MF
    Colorectal Dis; 2022 Aug; 24(8):954-964. PubMed ID: 35285992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery.
    Arredondo J; Baixauli J; Pastor C; Chopitea A; Sola JJ; González I; A-Cienfuegos J; Martínez P; Rodriguez J; Hernández-Lizoain JL
    Clin Transl Oncol; 2017 Mar; 19(3):379-385. PubMed ID: 27496023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 19. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
    Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
    World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Neoadjuvant Chemotherapy for Advanced Gastric Cancer in Elderly Patients.
    Mukoyama T; Kanaji S; Sawada R; Harada H; Urakawa N; Goto H; Hasegawa H; Yamashita K; Matsuda T; Oshikiri T; Kakeji Y
    Anticancer Res; 2023 Dec; 43(12):5649-5656. PubMed ID: 38030165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.